Eads & Heald Wealth Management raised its position in The Clorox Company (NYSE:CLX – Free Report) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,129 shares of the company’s stock after buying an additional 180 shares during the quarter. Eads & Heald Wealth Management’s holdings in Clorox were worth $1,320,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also modified their holdings of the company. Mizuho Securities USA LLC raised its position in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Ilex Capital Partners UK LLP raised its holdings in shares of Clorox by 512.7% in the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after buying an additional 453,624 shares during the last quarter. International Assets Investment Management LLC boosted its stake in shares of Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after buying an additional 435,971 shares during the period. Boston Trust Walden Corp boosted its stake in shares of Clorox by 5,442.5% during the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after buying an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. grew its holdings in shares of Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after buying an additional 265,455 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have weighed in on CLX. Barclays decreased their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and lifted their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. DA Davidson upped their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a report on Thursday, January 16th. Finally, Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $156.54.
Clorox Trading Down 0.2 %
Shares of CLX stock opened at $160.03 on Wednesday. The stock has a market cap of $19.81 billion, a P/E ratio of 55.76, a P/E/G ratio of 2.95 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The business has a fifty day simple moving average of $164.16 and a 200-day simple moving average of $156.91.
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period last year, the firm posted $0.49 EPS. On average, analysts forecast that The Clorox Company will post 6.87 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.05%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Most active stocks: Dollar volume vs share volume
- Super Micro Computer: Turning Risk Into Reward at the Crossroads
- Comparing and Trading High PE Ratio Stocks
- After a Reset Year, Is Moderna Stock Poised for a Comeback?
- How to Capture the Benefits of Dividend Increases
- Retail Trends Spark Analyst Upgrades for DICK’s Sporting Goods
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.